Benchmark initiated coverage on Alterity Therapeutics with a new price target

8/20/21 7:25:55 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Benchmark initiated coverage of Alterity Therapeutics with a rating of Speculative Buy and set a new price target of $4.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ATHE

Date	Price Target	Rating	Analyst
2/3/2025		Speculative Buy → Hold	The Benchmark Company
12/12/2024	$8.00	Buy	Maxim Group
8/20/2021	$4.00	Speculative Buy	Benchmark